| Literature DB >> 27368805 |
Iwan Kustiawan1, Ninotska Derksen1, Theo Rispens2.
Abstract
Pepsin is widely used to produce F(ab')2 fragments of immunoglobulin G (IgG). In many cases, at least part of the pepsin will remain present in the F(ab')2 preparation, albeit in (irreversibly) inactivated form. Here we report on a potent immunomodulatory effect of irreversibly inactivated pepsin on activated human neutrophils. Degranulation, induced by coated IgG or via cytochalasin B/N-formyl-Met-Leu-Phe, was measured by quantifying elastase release, and was found to be inhibited in a dose-dependent manner by inactivated pepsin. Since a number of intravenous immunoglobulin (IVIg) products are also treated by limited digestion with pepsin, we investigated if pepsin would be present in quantities large enough to inhibit neutrophil activation. The amounts of pepsin detected in three different pepsin-treated IVIg products were found to be too low to induce an effect, at least in an in vitro setting.Entities:
Keywords: Immunomodulation; Intravenous immunoglobulin (IVIg); Neutrophil; Pepsin
Mesh:
Substances:
Year: 2016 PMID: 27368805 DOI: 10.1016/j.clim.2016.06.008
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969